Par Pharmaceuticals and Chemicals Limited, a Gujarat-based corporation founded in 1999, manufactures and creates active pharmaceutical ingredients (API) for the domestic and global markets. Tablets, capsules, and other final doses are made mostly from APIs. The company also manufactures several antacid compounds.
In Gujarat, it has two production facilities, one each at Ankleshwar and Bhavnagar. The company currently offers 6 Fine Chemical products and 12 API products, which are sold in 17 different countries, including India. The company serves a number of clients, including Dabur India Ltd., Meyer Organics Pvt. Ltd., Cadila Healthcare Ltd., Cipla Ltd., and Pfizer Ltd. Domestic and overseas activities contributed 86.88% and 13.12%, respectively, of the total sales for the fiscal year 2018.The business maintains quality standards for both finished goods and raw materials through a testing facility. In addition to converting liquid items supplied by customers into powders, Par Pharmaceuticals and Chemicals Ltd. also dries the products.
Par Drugs IPO Details
| IPO Date | May 3, 2019 to May 8, 2019 |
| Listing Date | Thursday, May 16, 2019 |
| Face Value | ₹10 per share |
| Price | ₹51 per share |
| Lot Size | 2000 Shares |
| Issue Size | 1,672,000 shares of ₹10 (aggregating up to ₹8.53 Cr) |
| Fresh Issue | 1,672,000 shares of ₹10 (aggregating up to ₹[.] Cr) |
| Market Maker portion | 84,000 shares |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Falgun Vallabhbhai Savani and Jignesh Vallabhbhai Savani are the promoters of the company |
Par Drugs IPO Tentative Dates
Par Drugs IPO opens on May 3, 2019, and closes on May 8, 2019. The Par Drugs IPO bid date is from May 3, 2019 10.00 A.M. to May 8, 2019 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.
| Event | Tentative Date |
|---|---|
| Opening Date | May 3, 2019 |
| Closing Date | May 8, 2019 |
| Basis of Allotment | May 13, 2019 |
| Initiation of Refunds | May 14, 2019 |
| Credit of Shares to Demat | May 15, 2019 |
| Listing Date | May 16, 2019 |
Company Financials
| Particulars | For the year/period ended (in Rs. Lakhs) | |||
|---|---|---|---|---|
| 31-Mar-19 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
| Total Assets | 5,135.55 | 5,393.89 | 5,604.14 | 5,803.08 |
| Total Revenue | 4,641.20 | 4,241.65 | 4,880.90 | 3,326.43 |
| Profit After Tax | 241.88 | 149.53 | 184.78 | 42.18 |
Objects of the Issue
The following goals will be supported by the issue’s net proceeds:
1) financing the company’s need for operating cash
2) general business objectives
Par Drugs IPO Prospectus
Company Contact Information
Par Drugs and Chemicals Limited
805, Dwarkesh Complex,
R.C. Dutt Road,
Alkapuri, Vadodara-390 007,
Phone: +91 265 2332018
Email: cs.sanket@pardrugs.com
Website: http://pardrugs.com/
Par Drugs IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: pardrugs.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Par Drugs IPO Lead Manager(s)
- Pantomath Capital Advisors Pvt Ltd (Past IPO Performance)
